Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Tools of the Trade
  • Published:

The OrganiX microfluidic system to recreate the complex tumour microenvironment

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Microfluidic device for vascularized 3D tumour models.


  1. Lee, S. W. L. et al. Characterizing the role of monocytes in T cell cancer immunotherapy using a 3D microfluidic model. Front. Immunol. 9, 416 (2018).

    Article  PubMed  PubMed Central  Google Scholar 

  2. Lam, M. S. Y. et al. G9a/GLP inhibition during ex vivo lymphocyte expansion increases in vivo cytotoxicity of engineered T cells against hepatocellular carcinoma. Nat. Comm. 14, 563 (2023).

    Article  CAS  Google Scholar 

  3. Lam, M. S. et al. Unveiling the influence of tumor microenvironment and spatial heterogeneity on temozolomide resistance in glioblastoma using an advanced human in vitro model of the blood‐brain barrier and glioblastoma. Small 19, e2302280 (2023).

    Article  PubMed  Google Scholar 

  4. Vasudevan, J. et al. Microphysiological vascularized solid liver tumor model for drug and cell therapy [abstract 4612]. Cancer Res. 83, 4612 (2023).

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations


Corresponding authors

Correspondence to Giulia Adriani or Andrea Pavesi.

Ethics declarations

Competing interests

G.A. and A.P. are co-inventors on a US patent application (US20240018483A1) and an international patent application (WO 2022/197254 A1) describing microfluidic technologies and a method for 3D vascularization. G.A. and A.P. are co-inventors of the OrganiXTM plate, licensed to AIM Biotech. A.P. is a consultant and shareholder of AIM Biotech Pte. Ltd.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Adriani, G., Pavesi, A. The OrganiX microfluidic system to recreate the complex tumour microenvironment. Nat Rev Immunol 24, 307 (2024).

Download citation

  • Published:

  • Issue Date:

  • DOI:


Quick links

Nature Briefing: Cancer

Sign up for the Nature Briefing: Cancer newsletter — what matters in cancer research, free to your inbox weekly.

Get what matters in cancer research, free to your inbox weekly. Sign up for Nature Briefing: Cancer